147 related articles for article (PubMed ID: 16487125)
1. Lentiginous hyperpigmentation confined to resolved psoriatic plaques and treated with a Q-switched ruby laser.
Mitra A; Yeung R; Sheehan-Dare R; Wilson CL
Clin Exp Dermatol; 2006 Mar; 31(2):298-9. PubMed ID: 16487125
[No Abstract] [Full Text] [Related]
2. Multiple lentigines confined to a resolving psoriatic plaque, treated without phototherapy.
Rogers M
Clin Exp Dermatol; 1995 Sep; 20(5):446. PubMed ID: 8593731
[No Abstract] [Full Text] [Related]
3. Multiple lentigines confined to a resolving psoriatic plaque.
Martí N; Molina I; López V; Terradez L; Jordá E
Dermatol Online J; 2009 Oct; 15(10):15. PubMed ID: 19951633
[TBL] [Abstract][Full Text] [Related]
4. Treatment of nonmelanotic hyperpigmentation with the Q-switched ruby laser.
Becker-Wegerich PM; Kuhn A; Malek L; Lehmann P; Megahed M; Ruzicka T
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):272-4. PubMed ID: 10906650
[TBL] [Abstract][Full Text] [Related]
5. Localized chrysiasis induced by laser therapy.
Trotter MJ; Tron VA; Hollingdale J; Rivers JK
Arch Dermatol; 1995 Dec; 131(12):1411-4. PubMed ID: 7492130
[TBL] [Abstract][Full Text] [Related]
6. The use of lasers and intense pulsed light sources for the treatment of pigmentary lesions.
Chan HH; Kono T
Skin Therapy Lett; 2004 Oct; 9(8):5-7. PubMed ID: 15550991
[TBL] [Abstract][Full Text] [Related]
7. Development of chrysiasis after Q-switched ruby laser treatment of solar lentigines.
Geist DE; Phillips TJ
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S59-60. PubMed ID: 16843130
[No Abstract] [Full Text] [Related]
8. Characteristics of postinflammatory hyper- and hypopigmentation in patients with psoriasis: A survey study.
Amico S; Barnetche T; Dequidt L; Fauconneau A; Gérard E; Boursault L; Boniface K; Darrigade AS; Seneschal J;
J Am Acad Dermatol; 2020 Oct; 83(4):1188-1191. PubMed ID: 32068039
[No Abstract] [Full Text] [Related]
9. Delayed darkening of imipramine-induced hyperpigmentation after treatment with a Q-switched Nd:YAG laser followed by a Q-switched ruby laser.
Izikson L; Anderson RR
Dermatol Surg; 2009 Mar; 35(3):527-9. PubMed ID: 19250303
[No Abstract] [Full Text] [Related]
10. Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation.
Tafazzoli A; Rostan EF; Goldman MP
Dermatol Surg; 2000 Jul; 26(7):653-6. PubMed ID: 10886273
[TBL] [Abstract][Full Text] [Related]
11. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser.
Alster TS; Gupta SN
Dermatol Surg; 2004 Sep; 30(9):1201-4. PubMed ID: 15355359
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and adverse effects of Q-switched ruby laser on solar lentigines: a prospective study of 91 patients with Fitzpatrick skin type II, III, and IV.
Sadighha A; Saatee S; Muhaghegh-Zahed G
Dermatol Surg; 2008 Nov; 34(11):1465-8. PubMed ID: 18798756
[TBL] [Abstract][Full Text] [Related]
13. Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept.
Costa LA; Belinchón I; Betlloch I; Pérez-Crespo M; Mataix J
Dermatol Online J; 2008 Jan; 14(1):11. PubMed ID: 18319028
[TBL] [Abstract][Full Text] [Related]
14. [Effective removal of certain skin pigment spots (lentigenes) using the Q-switched ruby laser].
Brouwer PA; Meijer S
Ned Tijdschr Geneeskd; 1997 Apr; 141(17):843-4. PubMed ID: 9221367
[No Abstract] [Full Text] [Related]
15. Laugier-Hunziker syndrome: case report and treatment with the Q-switched Nd-Yag laser.
Ferreira MJ; Ferreira AM; Soares AP; Rodrigues JC
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):171-3. PubMed ID: 10343950
[TBL] [Abstract][Full Text] [Related]
16. Q-switched ruby laser treatment of minocycline-induced cutaneous hyperpigmentation.
Knoell KA; Milgraum SS; Kutenplon M
Arch Dermatol; 1996 Oct; 132(10):1251-3. PubMed ID: 8859046
[No Abstract] [Full Text] [Related]
17. Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser.
Tsao H; Busam K; Barnhill RL; Dover JS
Arch Dermatol; 1996 Oct; 132(10):1250-1. PubMed ID: 8859045
[No Abstract] [Full Text] [Related]
18. Multiple lentigines confined to psoriatic plaques.
Burrows NP; Handfield-Jones S; Monk BE; Sabroe RA; Geraghty JM; Norris PG
Clin Exp Dermatol; 1994 Sep; 19(5):380-2. PubMed ID: 7955492
[TBL] [Abstract][Full Text] [Related]
19. Multiple lentigines confined to resolving psoriatic plaques in a patient treated with adalimumab.
Santos-Juanes J; Coto P; Mallo S; Galache C; Sánchez del Río J; Torre JC
Dermatology; 2008; 216(3):279. PubMed ID: 18216489
[No Abstract] [Full Text] [Related]
20. Laser and novel light source treatments for psoriasis.
Tournas JA; Lowe NJ; Yamauchi PS
Lasers Surg Med; 2004; 35(3):165-73. PubMed ID: 15389742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
